PlainPharmaWatch

CMS Open Payments · Program Year 2024

Pharmacosmos Therapeutics Inc.

Pharmacosmos Therapeutics Inc. reported $1,726,720.75 in payments to 7,020 physicians and teaching hospitals across 7,110 transactions.

See the rankings → How this is sourced
$1.7M
Total payments
7,110
Transactions
7,020
Recipients
+$350.1K
General Payments vs PY2023

Pharmacosmos Therapeutics Inc. reported $1,726,720.75 in payments to 7,020 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #486 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $245.97 per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Pharmacosmos Therapeutics Inc. pairs above-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#486
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Pharmacosmos Therapeutics Inc.'s CMS-reported General Payments increased by $350.1K (+31.9%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: PHARMACOSMOS THERAPEUTICS INC.PY2023: PHARMACOSMOS THERAPEUTICS INC.PY2024: Pharmacosmos Therapeutics Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.1MPY2024$1.4M
PY2023
$1,095,836.22
PY2024
$1,445,949.85

How Pharmacosmos Therapeutics Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Pharmacosmos Therapeutics Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,726,721 Top 25% higher than 75% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Pharmacosmos Therapeutics Inc.

Averaging $242.86 per transaction and $245.97 per recipient, Pharmacosmos Therapeutics Inc.'s Program Year 2024 total comes to $1,726,720.75 across 7,110 transactions and 7,020 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #486 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Honoraria" at $746.1K, accounting for 43.2% of the company's reported total and 169 transactions.

General Payment Breakdown by Type

"Honoraria" leads Pharmacosmos Therapeutics Inc.'s 4-category general-payment breakdown at $746.1K, 43.2% of the reported total.

How Pharmacosmos Therapeutics Inc. divides its payments

How the reported total splits across payment categories

1. Honoraria$746.1K2. Travel and Lodging$287.2K3. Consulting Fee$215.0K4. Food and Beverage$197.6K
Payment Type Amount Transactions
Honoraria $746.1K 169
Travel and Lodging $287.2K 407
Consulting Fee $215.0K 30
Food and Beverage $197.6K 6,414

Recipient Concentration in General Payments

The five largest recipient relationships account for $452,420.85 (31.3%) of $1,445,949.85 in this company's General Payments records across 4,138 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Pharmacosmos Therapeutics Inc.

The five named recipients with the highest reported General Payments from this company

Aryeh Shander$142.9KMyles Wolf$136.0KSuresh Ratnam$62.9KChristopher Chen$57.9KHassan Kaleem$52.6K
  1. 1

    Aryeh Shander

    $142,933.50 across 15 reported transactions

  2. 2

    Myles Wolf

    $136,015.91 across 19 reported transactions

  3. 3

    Suresh Ratnam

    $62,918.96 across 38 reported transactions

  4. 4

    Christopher Chen

    $57,920.56 across 103 reported transactions

  5. 5

    Hassan Kaleem

    $52,631.92 across 77 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $242.86. Average per recipient: $245.97.

Total Amount

$1,726,720.75

Avg per Transaction

$242.86

Avg per Recipient

$245.97

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Pharmacosmos Therapeutics Inc. Share

0.0%

#486 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Pharmacosmos Therapeutics Inc.

Y-mAbs Therapeutics, Inc.

$1.7M 159 recipients

Dompe US, Inc.

$1.7M 11,308 recipients

Esperion Therapeutics, Inc.

$1.7M 27,251 recipients

bioMerieux Inc

$1.7M 600 recipients

Radiometer America, Inc

$1.7M 84 recipients

Medivation LLC.

$1.7M 3 recipients

Frequently Asked Questions

How much did Pharmacosmos Therapeutics Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $1,726,720.75 from Pharmacosmos Therapeutics Inc. to physicians and hospitals across 7,110 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Pharmacosmos Therapeutics Inc.? ▾
Averaging $245.97 per recipient, Pharmacosmos Therapeutics Inc.'s 2024 payments reached 7,020 physicians and teaching hospitals.
What types of payments did Pharmacosmos Therapeutics Inc. make? ▾
Pharmacosmos Therapeutics Inc. made 4 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Honoraria" at $746.1K, representing 43.2% of the company's reported total.
How does Pharmacosmos Therapeutics Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Pharmacosmos Therapeutics Inc. ranks #486 by total payment amount.
What is the average payment size from Pharmacosmos Therapeutics Inc.? ▾
The average transaction from Pharmacosmos Therapeutics Inc. was $242.86 in 2024. The company made 7,110 total transactions to 7,020 recipients.
Where does the payment data for Pharmacosmos Therapeutics Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Pharmacosmos Therapeutics Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.